Latest Breaking News On - Perceptive life sciences - Page 1 : comparemela.com

This Legendary Billionaire Biotech Investor Has Remained A Mystery—Until Now

In an exclusive excerpt from For Blood And Money, the untold story of Wayne Rothbaum and the worst trade of his life. But what cost him some $700 million turned out to be the boon for countless cancer patients.

IPO Update: Acrivon Therapeutics Readies $100 Million IPO

Acrivon Therapeutics has filed proposed terms for a $100 million U.S. IPO. Click here to read more about ACRV stock and about the IPO.

Acrivon Therapeutics (ACRV) Begins U.S. IPO Rollout

Acrivon Therapeutics has filed to raise $119 million in an IPO, although the final figure may differ. Click here to learn more about ACRV IPO.

Q2 wraps up with more than $6.2 billion in digital health investments

Startup making digital therapeutic for pelvic floor disorders raises $17M

MedCity News Startup making digital therapeutic for pelvic floor disorders raises $17M Renovia, a digital health startup that developed an app-based program for urinary incontinence, raised $17 million in funding. The company recently completed a clinical trial that it plans to share with insurance carriers as evidence of its efficacy.  Shares0 Women’s health startup Renovia raised $17 million to market its lead product, a digital therapeutic for pelvic floor disorders. Photo credit: Renovia Boston-based startup Renovia raised $17 million for its digital therapeutic, designed to help people with exercises for pelvic floor disorders. The company plans to use the funds to market its lead product, which received FDA clearance in late 2019.